Découverte fortuite d’une atteinte hépatique d’amylose à leukocyte chemotactic factor 2

Archive ouverte

Gibier, Jean-Baptiste | Gilbertson, Janet A. | Perbet, Romain | Leriche, William | Truant, Stéphanie | Leteurtre, Emmanuelle | Gillmore, Julian D. | Gnemmi, Viviane

Edité par CCSD ; Elsevier Masson -

International audience. Leukocyte cell-derived chemotaxin 2-associated amyloidosis (ALECT2) is a recently described of amyloidosis described in the United States in 2007. It is a systemic disease that is predominantly associated with some ethnics groups. ALECT2 is usually diagnosed on a kidney biopsy performed in the context of slowly progressive chronic renal disease but can also be found incidentally on a liver sample. We report the case of a Syrian patient who benefited from a partial hepatectomy for the treatment of multiple metastasis of a colorectal adenocarcinoma. Microscopic analysis of the surgical specimen revealed numerous amyloid deposits that did not match any of the usual forms of liver amyloidosis after immunohistochemistry typing. Some morphologic features of the deposits were highly suggestive of ALECT2. Complementary immunohistochemical study and mass spectrometry confirmed the diagnosis.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion